Physician profile
Robert Gooding Mcalpine
NPI 1376507327
$578.98
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $325 · 2020: $191 · 2022: $14.23 · 2023: $48.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $48.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $48.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $199.95 | 2019-2020 | |
| Neotract INC. | $146.07 | 2020 | |
| Coloplast Corp | $47.22 | 2019-2020 | |
| Rochester Medical Corporation | $45.06 | 2019 | |
| Boston Scientific Corporation | $33.42 | 2019-2023 | Spaceoar Vue System - 10ml |
| Pfizer INC. | $18.51 | 2019 | |
| Travere Therapeutics, INC. | $16.59 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.06 | 2023 | |
| Cook Medical LLC | $15.90 | 2019 | |
| Abbvie INC. | $14.23 | 2022 | |
| Novo Nordisk INC | $13.01 | 2023 | Rybelsus, Ozempic |
| Allergan, INC. | $12.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Mcalpine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.